DDM:NYE-ProShares Ultra Dow30

ETF | Drug Manufacturers | NYE

Last Closing Price

USD 49.10


-0.12 (-0.24)%

Market Cap

USD 0.36B



Average Target Price

Average Analyst Rating


STA Verdict



The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones Industrial AverageSM Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a price-weighted index and includes 30 large-cap, blue-chip U.S. stocks, excluding utility and transportation companies. The fund is non-diversified.

Inception Date: 19/06/2006

Primary Benchmark: DJ Industrial Average TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.0%

Management Expense Ratio: 0.95 %

Market Stats

Unadjusted Closing Price

Adjusted Closing Price



Top Sectors


Top Regions


Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Relative Returns (From:    To: 2019-10-22 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Mer Price(Change) Market Cap
SSO ProShares Ultra S&P500 0.90 %

-0.97 (-0.74%)

USD 2.40B
QLD ProShares Ultra QQQ 0.95 %

-1.62 (-1.60%)

USD 1.90B
UYG ProShares Ultra Financials 0.95 %

-0.66 (-1.37%)

USD 0.80B
PSQ ProShares Short QQQ 0.95 %

+0.21 (+0.78%)

USD 0.50B
DOG ProShares Short Dow30 0.95 %

+0.07 (+0.13%)

USD 0.22B
UWM ProShares Ultra Russell2000 0.95 %

+0.04 (+0.06%)

USD 0.17B
DXD ProShares UltraShort Dow30 0.95 %

+0.06 (+0.23%)

USD 0.16B
MVV ProShares Ultra MidCap400 0.95 %

-0.03 (-0.07%)

USD 0.14B
URE ProShares Ultra Real Estate 0.95 %

-0.70 (-0.77%)

USD 0.14B
EUO ProShares UltraShort Euro 0.95 %

+0.10 (+0.37%)

USD 0.13B

ETFs Containing DDM

Symbol Name Weight Mer Price(Change) Market Cap


Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Capital Gain 29.83% 74% C 84% B
Dividend Return 0.52% 18% F 7% F
Total Return 30.35% 74% C 82% B-
Trailing 12 Months  
Capital Gain 8.99% 58% F 66% D
Dividend Return 0.62% 9% F 7% F
Total Return 9.61% 55% F 59% F
Trailing 5 Years  
Capital Gain 156.75% 94% A 94% A
Dividend Return 7.60% 87% B+ 25% F
Total Return 164.35% 94% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 22.55% 95% A 93% A
Dividend Return 1.10% 65% D 25% F
Total Return 23.65% 95% A 93% A
Risk Return Profile  
Volatility (Standard Deviation) 23.87% 26% F 28% F
Risk Adjusted Return 99.09% 87% B+ 89% B+
Market Capitalization 0.36B 89% B+ 39% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.